{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:54:42Z","timestamp":1757620482095,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Garvey Institute for Brain Health Solutions, University of Washington Department of Psychiatry and Behavioral Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07132-4","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:58:08Z","timestamp":1753948688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cAll I want is the best for my brother\u201d: interest in a Community Reinforcement and Family Training (CRAFT)-based group intervention among concerned significant others of individuals on office-based medications for opioid use disorder"],"prefix":"10.1186","volume":"25","author":[{"given":"Mandy D.","family":"Owens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Addy","family":"Adwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samyukta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Osilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Tweedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"4","key":"7132_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/add.13238","volume":"111","author":"Y Hser","year":"2016","unstructured":"Hser Y, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, et al. Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial. Addiction. 2016;111(4):695\u2013705.","journal-title":"Addiction"},{"issue":"3","key":"7132_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality. Ann Intern Med. 2018;169(3):137.","journal-title":"Ann Intern Med."},{"issue":"2","key":"7132_CR3","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open. 2020;3(2):e1920622.","journal-title":"JAMA Netw Open."},{"issue":"7","key":"7132_CR4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1176\/appi.ps.201700363","volume":"69","author":"A Manhapra","year":"2018","unstructured":"Manhapra A, Agbese E, Leslie DL, Rosenheck RA. Three-year retention in buprenorphine treatment for opioid use disorder among privately insured adults. Psychiatr Serv. 2018;69(7):768\u201376.","journal-title":"Psychiatr Serv."},{"key":"7132_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","volume":"20","author":"MD Stein","year":"2005","unstructured":"Stein MD, Cioe P, Friedmann PD. Brief report: Buprenorphine retention in primary care. J Gen Intern Med. 2005;20:1038\u201341.","journal-title":"J Gen Intern Med."},{"key":"7132_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","volume":"74","author":"ZM Weinstein","year":"2017","unstructured":"Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, et al. Long-term retention in office based opioid treatment with buprenorphine. J Subst Abuse Treat. 2017;74:65\u201370.","journal-title":"J Subst Abuse Treat."},{"issue":"April","key":"7132_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jsat.2019.10.005","volume":"109","author":"JI Tsui","year":"2020","unstructured":"Tsui JI, Mayfield J, Speaker EC, Yakup S, Ries R, Funai H, et al. Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. J Subst Abuse Treat. 2020;109(April):80\u20135.","journal-title":"J Subst Abuse Treat."},{"issue":"5","key":"7132_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/ADM.0000000000000331","volume":"11","author":"AS Ventura","year":"2017","unstructured":"Ventura AS, Bagley SM. To improve substance use disorder prevention, treatment and recovery: Engage the family. J Addict Med. 2017;11(5):339\u201341.","journal-title":"J Addict Med."},{"issue":"6","key":"7132_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/ajad.13457","volume":"32","author":"M Kidorf","year":"2023","unstructured":"Kidorf M, Peirce J, Brooner RK, Yan H, Latkin C. Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder. Am J Addict. 2023;32(6):554\u201362.","journal-title":"Am J Addict."},{"issue":"1","key":"7132_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jsat.2011.10.020","volume":"43","author":"JK Manuel","year":"2012","unstructured":"Manuel JK, Austin JL, Miller WR, McCrady BS, Tonigan JS, Meyers RJ, et al. Community Reinforcement and Family Training: A pilot comparison of group and self-directed delivery. J Subst Abuse Treat. 2012;43(1):129\u201336.","journal-title":"J Subst Abuse Treat."},{"issue":"3","key":"7132_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0899-3289(99)00003-6","volume":"10","author":"RJ Meyers","year":"1998","unstructured":"Meyers RJ, Miller WR, Hill DE, Tonigan JS. Community reinforcement and family training (CRAFT): Engaging unmotivated drug users in treatment. J Subst Abuse. 1998;10(3):291\u2013308.","journal-title":"J Subst Abuse."},{"issue":"5","key":"7132_CR12","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1037\/0022-006X.70.5.1182","volume":"70","author":"RJ Meyers","year":"2002","unstructured":"Meyers RJ, Miller WR, Smith JE, Tonigan JS. A randomized trial of two methods for engaging treatment-refusing drug users through concerned significant others. J Consult Clin Psychol. 2002;70(5):1182.","journal-title":"J Consult Clin Psychol."},{"issue":"5","key":"7132_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1037\/0022-006X.67.5.688","volume":"67","author":"WR Miller","year":"1999","unstructured":"Miller WR, Meyers RJ, Tonigan JS. Engaging the unmotivated in treatment for alcohol problems: a comparison of three strategies for intervention through family members. J Consult Clin Psychol. 1999;67(5):688.","journal-title":"J Consult Clin Psychol."},{"issue":"6","key":"7132_CR14","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/add.14901","volume":"115","author":"M Archer","year":"2020","unstructured":"Archer M, Harwood H, Stevelink S, Rafferty L, Greenberg N. Community reinforcement and family training and rates of treatment entry: A systematic review. Addiction. 2020;115(6):1024\u201337.","journal-title":"Addiction."},{"issue":"10","key":"7132_CR15","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/j.1360-0443.2010.03016.x","volume":"105","author":"HG Roozen","year":"2010","unstructured":"Roozen HG, De Waart R, Van Der Kroft P. Community reinforcement and family training: An effective option to engage treatment-resistant substance-abusing individuals in treatment. Addiction. 2010;105(10):1729\u201338.","journal-title":"Addiction."},{"issue":"3\u20134","key":"7132_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/19371918.2013.759005","volume":"28","author":"L Lander","year":"2013","unstructured":"Lander L, Howsare J, Byrne M. The impact of substance use disorders on families and children: from theory to practice. Soc Work Public Health. 2013;28(3\u20134):194\u2013205.","journal-title":"Soc Work Public Health."},{"key":"7132_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.drugalcdep.2014.02.013","volume":"138","author":"GS Brigham","year":"2014","unstructured":"Brigham GS, Slesnick N, Winhusen TM, Lewis DF, Guo X, Somoza E. A randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification. Drug Alcohol Depend. 2014;138:240\u20133.","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"7132_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jama.2019.18913","volume":"323","author":"M Olfson","year":"2020","unstructured":"Olfson M, Zhang VS, Schoenbaum M, King M. Trends in buprenorphine treatment in the United States, 2009\u20132018. Jama. 2020;323(3):276\u20137.","journal-title":"Jama."},{"key":"7132_CR19","doi-asserted-by":"publisher","first-page":"109933","DOI":"10.1016\/j.drugalcdep.2023.109933","volume":"248","author":"MR Larochelle","year":"2023","unstructured":"Larochelle MR, Jones CM, Zhang K. Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016\u20132021. Drug Alcohol Depend. 2023;248:109933.","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"7132_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-020-00199-2","volume":"15","author":"KC Osilla","year":"2020","unstructured":"Osilla KC, Becker K, Ecola L, Hurley B, Manuel JK, Ober A, et al. Study design to evaluate a group-based therapy for support persons of adults on buprenorphine\/naloxone. Addict Sci Clin Pract. 2020;15(1):1\u201311.","journal-title":"Addict Sci Clin Pract."},{"key":"7132_CR21","doi-asserted-by":"publisher","first-page":"209290","DOI":"10.1016\/j.josat.2024.209290","volume":"161","author":"KC Osilla","year":"2024","unstructured":"Osilla KC, Manuel JK, Becker K, Nameth K, Burgette L, Ober AJ, et al. It takes a village: A pilot study of a group telehealth intervention for support persons affected by opioid use disorder. J Subst Use Addict Treat. 2024;161:209290.","journal-title":"J Subst Use Addict Treat."},{"issue":"1","key":"7132_CR22","first-page":"80","volume":"2","author":"LW Dutcher","year":"2009","unstructured":"Dutcher LW, Anderson R, Moore M, Luna-Anderson C, Meyers RJ, Delaney HD, et al. Community Reinforcement and Family Training (CRAFT): An effectiveness study. J Behav Anal Health Sports Fit Med. 2009;2(1):80.","journal-title":"J Behav Anal Health Sports Fit Med."},{"key":"7132_CR23","volume-title":"IBM SPSS Statistics for Windows","author":"IBM","year":"2020","unstructured":"IBM. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp.; 2020."},{"issue":"5","key":"7132_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/NNR.0000000000000442","volume":"69","author":"MB Tyo","year":"2020","unstructured":"Tyo MB, McCurry MK. An integrative review of measuring caregiver burden in substance use disorder. Nurs Res. 2020;69(5):391\u20138.","journal-title":"Nurs Res."},{"issue":"2","key":"7132_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol."},{"key":"7132_CR26","doi-asserted-by":"publisher","first-page":"108652","DOI":"10.1016\/j.jsat.2021.108652","volume":"132","author":"AR Dopp","year":"2022","unstructured":"Dopp AR, Manuel JK, Breslau J, Lodge B, Hurley B, Kase C, et al. Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities. J Subst Abuse Treat. 2022;132:108652.","journal-title":"J Subst Abuse Treat."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07132-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07132-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07132-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:48:58Z","timestamp":1757321338000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07132-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7132"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07132-4","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were approved by the University of Washington Institutional Review Board in concordance with the Declaration of Helsinki, the Council for International Organizations of Medical Sciences and the International Council for Harmonization. Clinical trial number: Not applicable. All participants provided consent. Study data are available de-identified from the corresponding author on reasonable request. The authors declare that they have no competing interests. MDO led study design, data collection and analysis, and writing the manuscript. AA and SS assisted with data collection and analysis. KO, MT, and JT all provided input to study design and interpretation of the results. All authors read, edited, and approved the final manuscript for publication. We appreciate the assistance of Harborview Medical Center staff to make this study happen. Thank you to the study participants and their friends and family members for sharing their experiences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"748"}}